בטאקורטן משחה Izrael - hebrejčina - Ministry of Health

בטאקורטן משחה

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate - משחה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions.

בטאקורטן G משחה Izrael - hebrejčina - Ministry of Health

בטאקורטן g משחה

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - משחה - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

בטאקורטן תמיסה לקרקפת Izrael - hebrejčina - Ministry of Health

בטאקורטן תמיסה לקרקפת

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate - תמיסה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - a specific treatment for dermatoses of the scalp.

דרמובט משחה Izrael - hebrejčina - Ministry of Health

דרמובט משחה

glaxo smith kline (israel) ltd - clobetasol 17- propionate - משחה - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

דרמובט קרם Izrael - hebrejčina - Ministry of Health

דרמובט קרם

glaxo smith kline (israel) ltd - clobetasol 17- propionate - קרם - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

בטאקורטן G קרם Izrael - hebrejčina - Ministry of Health

בטאקורטן g קרם

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - קרם - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone and antibiotics - betamethasone and antibiotics - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.

גנוטרופין 5.3 מג Izrael - hebrejčina - Ministry of Health

גנוטרופין 5.3 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 5.3 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth weight and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

גנוטרופין 12 מג Izrael - hebrejčina - Ministry of Health

גנוטרופין 12 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 12 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

פורטאו Izrael - hebrejčina - Ministry of Health

פורטאו

eli lilly israel ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 250 mcg/ml - teriparatide - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, forteo increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:forteo is indicated for the treatment of men and women with osteopo

אציקלו-וי 200 Izrael - hebrejčina - Ministry of Health

אציקלו-וי 200

cts chemical industries ltd, israel - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. suppression of recurrent herpes simplex infections. prophylaxis of herpes simplex infections in immune compromised patients. treatment of herpes zoster infections. for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: patients over 13 years of age who are otherwise healthy. children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. children receiving short or intermittent courses of aerosolized corticosteroids. the drug should not be taken if more than 24 hours passed from the onset of a typical chickenpox rash.